207 related articles for article (PubMed ID: 10491378)
1. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
[TBL] [Abstract][Full Text] [Related]
2. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
3. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Wang D; Huang Y
Mol Vis; 2012; 18():624-33. PubMed ID: 22509094
[TBL] [Abstract][Full Text] [Related]
4. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
[TBL] [Abstract][Full Text] [Related]
5. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
[TBL] [Abstract][Full Text] [Related]
6. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
Wang MH; Milekhin V; Zhang H; Huang HZ
Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
[TBL] [Abstract][Full Text] [Related]
7. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs.
Furukawa H; Suzuki T; Jin MB; Yamashita K; Taniguchi M; Magata S; Ishikawa H; Ogata K; Masuko H; Shimamura T; Fukai M; Hayashi T; Fujita M; Nagashima K; Omura T; Kishida A; Todo S
Transplantation; 2000 Jan; 69(2):235-41. PubMed ID: 10670633
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft.
Cheng Q; Li D; Liang H; Yang H; Lei D; Gao D; Long X; Chen Y; Zhu P; Chen X
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):199-204. PubMed ID: 22528220
[TBL] [Abstract][Full Text] [Related]
10. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
11. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation].
Xiong HB; Huang ZF; Ye QF; Xia SS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):41-6. PubMed ID: 17344585
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
14. FTY720 and cyclosporin protect ovarian tissue grafted into rabbits.
Ying Y; Wang L; Chen Y; Jiang J; Ouyang Y; Huang H; Xu J
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):88-95. PubMed ID: 24035595
[TBL] [Abstract][Full Text] [Related]
15. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.
Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V
Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.
Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S
Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526
[No Abstract] [Full Text] [Related]
17. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
[TBL] [Abstract][Full Text] [Related]
18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
Miyamoto T; Matsumori A; Hwang MW; Nishio R; Ito H; Sasayama S
J Am Coll Cardiol; 2001 May; 37(6):1713-8. PubMed ID: 11345389
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
